Securities Class Action Filed Against MiMedx Group, Inc.

Violations of federal securities laws as a result of a series of materially false statements. The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects, including that: (1) it was in violation of federal regulations by engaging in improper marketing and sales practices; and (2) as a result of the foregoing, the Company’s statements were materially false and misleading at all relevant times. On December 31, 2014, after the close of trading, the Company issued a press release announcing the receipt of a civil subpoena from the Office of Inspector General of the Department of Health and Human Services. Moreover, the Company announced the same day that it had filed a lawsuit against one of its competitors, Organogenesis, Inc., for tortious interference of contract, alleging that it had interfered with MiMedx’s dealings with the Veterans’ Administration. Within a matter of weeks, MiMedx voluntarily dismissed the lawsuit. On this news, MiMedx securities declined $1.79 per share, or by more than 15%, to close at $9.74 per share on January 2, 2015, the next trading day. Filed in S.D.N.Y.

Lead Plaintiff Deadline: The deadline to file for lead plaintiff in this action is 4/20/2015.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah, LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.

A Message to Our Clients About Coronavirus COVID-19:

A Message to Our Clients About Coronavirus COVID-19

At Shepherd, Finkelman, Miller & Shah, LLP, we view the safety and well-being of our clients, staff and business partners as our highest priority.

The situation regarding the COVID-19 virus is continually changing, and we are following all recommended guidelines to stay healthy. As a result, our lawyers and staff are working remotely in accordance with the CDC's recommendations. We continue to work for all of our clients and are happy to arrange for phone or video consultations. We are also able to exchange documents via secure drives or email.

Please contact us online or call 866-540-5505 with any questions.

Thank you and take care.